A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
Clinical trial NCT03878446 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03878446
- Sponsor
- Novo Nordisk A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-04
- Primary completion
- 2021-05-05
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.